SemBioSys and Tasly Pharmaceutical to participate in the 5th Canada-China Business Forum and Signing Ceremony
New Joint Venture Focused on Multi-Million Dollar Short-Term Revenue Opportunities
CALGARY, Feb. 8, 2012 /CNW/ - SemBioSys Genetics Inc. (TSX:SBS), today announced that it will be present at the 5th Canada-China Business Forum (CCBF) and Signing Ceremony on February 9, 2012, in Beijing, China. SemBioSys and its Chinese partner, Tasly Pharmaceutical Co., Ltd. are to sign supplementary documents necessary to establish the recently People's Republic of China approved Joint Venture. The Joint Venture, based in Tianjin, China, called Tasly-SemBioSys Bio-Pharmaceutical Technology Co., Ltd., will commercialize near, medium, and long term healthy living, nutritional, and pharmaceutical products utilizing Tasly and SemBioSys' plant-based technology and expertise.
"The common values and scientific principles we share with Tasly Pharmaceutical and their approach to traditional Chinese medicine and biological drugs made our partnership a natural step in the progression of SemBioSys," said James Szarko, President and CEO of SemBioSys. "It is an honour to confirm our agreement at the Signing Ceremony and in the presence of Canada's own Prime Minister Harper."